Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 943,999 | 752,164 | 612,045 | 528,285 | 529,857 |
| Marketable Securities | 1,017,567 | 1,029,543 | 982,317 | 1,029,193 | 984,994 |
| Receivables | 432,888 | 436,467 | 440,699 | 429,021 | 421,752 |
| Inventories | 176,441 | 140,044 | 144,859 | 126,154 | 102,602 |
| Income taxes - deferred | N/A | 54,381 | 50,281 | 45,871 | 41,432 |
| TOTAL | $2,796,029 | $2,559,878 | $2,341,306 | $2,245,880 | $2,186,857 |
| Non-Current Assets | |||||
| PPE Net | 392,248 | 328,476 | 273,326 | 218,086 | 201,109 |
| Intangibles | 841,119 | 851,333 | 853,859 | 857,094 | 863,792 |
| Other Non-Current Assets | 172,566 | 151,200 | 85,319 | 58,606 | 65,938 |
| TOTAL | $1,405,933 | $1,331,009 | $1,212,504 | $1,133,786 | $1,130,839 |
| Total Assets | $4,201,962 | $3,890,887 | $3,553,810 | $3,379,666 | $3,317,696 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 |
| Accounts payable and accrued liabilities | 44,016 | 23,175 | 36,066 | 35,339 | 21,596 |
| Accrued Expenses | 395,232 | 278,265 | 204,743 | 196,369 | 402,344 |
| Other current liabilities | 60,655 | 54,286 | 56,621 | 58,255 | 56,688 |
| TOTAL | $606,740 | $502,537 | $417,701 | $396,822 | $582,429 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,500 | 21,500 | 33,500 | 45,500 | 65,000 |
| Deferred Revenues | 58,837 | 98,811 | 72,271 | 58,859 | 53,801 |
| aiOther Non-Current Liabilities | 169,559 | 151,810 | 161,416 | 151,963 | 154,717 |
| TOTAL | $293,204 | $265,311 | $254,527 | $281,866 | $353,188 |
| Total Liabilities | $899,944 | $767,848 | $672,228 | $678,688 | $935,617 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 202,149 | 198,287 | 197,815 | 197,796 | 197,830 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | 1,036,010 | 882,678 | 704,947 | 538,452 | 379,098 |
| Other shareholders' equity | 56,821 | 48,987 | -32,330 | -26,857 | -23,222 |
| TOTAL | $3,302,018 | $3,123,039 | $2,881,582 | $2,700,978 | $2,382,079 |
| Total Liabilities And Equity | $4,201,962 | $3,890,887 | $3,553,810 | $3,379,666 | $3,317,696 |